Please provide your email address to receive an email when new articles are posted on . BOSTON — Smartphone-enabled ECG sensors can detect atrial fibrillation in ...

A mail-based atrial fibrillation (AF) screening programme with ECG-patch monitoring led to a modest long-term increase in AF diagnosis and anticoagulation exposure in older patients at ...

New decision establishes reimbursement for the clinical use of Tempus ECG-AF, reducing the financial burden of using AI to improve early detection of atrial fibrillation CHICAGO, December 17, ...

Continuous cardiac monitoring using a home-based, wearable electrocardiogram (ECG) sensor patch may improve early detection of atrial fibrillation (AF) in high-risk patients, new research shows.

MADRID, Spain—The use of a noninvasive ECG patch modestly increases the detection of atrial fibrillation (AF) and treatment with anticoagulant therapy among patients at moderate to high risk for ...

CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a leader in artificial intelligence and precision medicine, today announced it has received 510(k) clearance from the U.S. Food and Drug ...

MOUNTAIN VIEW, Calif., Jan. 7, 2022 /PRNewswire/ -- AliveCor, the global leader in FDA-cleared personal electrocardiogram (ECG) technology, today announced that the National Institute for Health and ...

1 Department of Family Medicine, University of Washington, Seattle, Washington, USA 2 Division of Ciology, University of Washington, Seattle, Washington, USA 3 Division of Ciology, Seattle Children's ...

Department of Family Medicine, University of Washington, Seattle, Washington, USA Correspondence to Professor Jonathan A Drezner, Department of Family Medicine, University of Washington, P.O. Box ...

CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced the impact of a new decision by ...